Skip to main navigation
Quantum Si
  • Technology
    • Overview
    • Resources
  • Products
    • Overview
    • Platinum
    • Assay & Workflow
    • Cloud
    • Carbon
  • Leadership
  • Investors
    • News
    • Events and Presentations
    • Stock Information
    • Financials
    • Governance
    • Investor Resources
  • Careers
  • Contact
Select Page
h
    • Technology
      • Overview
      • Resources
    • Products
      • Overview
      • Platinum
      • Assay & Workflow
      • Cloud
      • Carbon
    • Leadership
    • Investors
      • News
      • Events and Presentations
      • Stock Information
      • Financials
      • Governance
      • Investor Resources
    • Careers
    • Contact

News Details

  • Overview
  • News
  • Events & Presentations
    Events Presentations
  • Stock Information
    Stock Quote & Chart Analyst Coverage Historic Price Lookup
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Highlights Executive Management Board of Directors Committee Composition
  • Investor Resources
    Investor FAQs Investor Email Alerts Investor Contact

Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

February 13, 2023
PDF Version

GUILFORD, Conn.--(BUSINESS WIRE)--Feb. 13, 2023-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the fourth quarter and full year 2022 before market open on Monday, March 6, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET.

Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230213005545/en/

Investor
Juan Avendano
ir@quantum-si.com

Media
Michael Sullivan
media@quantum-si.com

Source: Quantum-Si Incorporated

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR
h
© Copyright 2023 QuantumSi | All rights reserved.
Follow us
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • Youtube